Sumitomo Mitsui Trust Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,910,232
Closed -$289M 1139
2019
Q3
$289M Buy
2,910,232
+4,542
+0.2% +$432K 0.25% 86
2019
Q2
$269M Sell
2,905,690
-84,457
-3% -$8.02M 0.24% 85
2019
Q1
$282M Buy
2,990,147
+28,374
+1% +$2.48M 0.26% 82
2018
Q4
$185M Buy
2,961,773
+334,052
+13% +$24.7M 0.2% 114
2018
Q3
$235M Sell
2,627,721
-20,760
-0.8% -$1.83M 0.25% 86
2018
Q2
$210M Buy
2,648,481
+268,597
+11% +$22.3M 0.25% 86
2018
Q1
$212M Buy
2,379,884
+89,641
+4% +$8.61M 0.27% 82
2017
Q4
$239M Sell
2,290,243
-137,630
-6% -$15.5M 0.31% 70
2017
Q3
$354M Sell
2,427,873
-20,830
-0.9% -$2.84M 0.5% 43
2017
Q2
$318M Buy
2,448,703
+92,435
+4% +$11.3M 0.47% 42
2017
Q1
$293M Buy
2,356,268
+8,199
+0.3% +$981K 0.45% 44
2016
Q4
$272M Buy
2,348,069
+23,082
+1% +$2.57M 0.44% 46
2016
Q3
$243M Sell
2,324,987
-163,778
-7% -$17.7M 0.4% 49
2016
Q2
$245M Buy
2,488,765
+20,006
+0.8% +$2.07M 0.42% 46
2016
Q1
$247M Buy
2,468,759
+244,661
+11% +$25.2M 0.43% 46
2015
Q4
$268M Sell
2,224,098
-2,418
-0.1% -$280K 0.48% 44
2015
Q3
$241M Sell
2,226,516
-166,272
-7% -$20.6M 0.47% 44
2015
Q2
$277M Buy
2,392,788
+198,326
+9% +$22.7M 0.5% 39
2015
Q1
$253M Buy
2,194,462
+297,241
+16% +$35.5M 0.46% 46
2014
Q4
$215M Sell
1,897,221
-38,560
-2% -$4.07M 0.42% 52
2014
Q3
$183M Sell
1,935,781
-274,040
-12% -$24.7M 0.37% 59
2014
Q2
$190M Buy
2,209,821
+38,723
+2% +$2.94M 0.39% 54
2014
Q1
$152M Buy
2,171,098
+22,470
+1% +$1.78M 0.32% 74
2013
Q4
$182M Sell
2,148,628
-116,838
-5% -$9.25M 0.38% 57
2013
Q3
$175M Buy
2,265,466
+6,080
+0.3% +$426K 0.38% 60
2013
Q2
$132M Buy
+2,259,386
New +$136M 0.3% 75

Other funds holding CELG

Sumitomo Mitsui Trust Group's CELG Position: Q4 2019 in Review

Sumitomo Mitsui Trust Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,910,232 shares — an estimated $289M sold.

Sumitomo Mitsui Trust Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $354M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Sumitomo Mitsui Trust Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 2,910,232 Celgene Corp shares in Q4 2019, an estimated $289M.
  • Sumitomo Mitsui Trust Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Sumitomo Mitsui Trust Group's Celgene Corp position peaked at $354M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q4 2019, filed 31 Jan 2020.